1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Sinew Pharma Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Novel, Potent and Non-addictive Analgesic of Combinations for Knee Replacement Moderate to Severe Pain Management Naldebain, SafeTynadol, Naldebain + SafeTynadol - Pain, Postoperative | Phase 2 | Unknown | Sinew Pharma Inc. | 36 | 2023-07-25 | 2023-07-27 |
Taiwan (1)